miRNA-Processing Gene Variants and Neuroblastoma Susceptibility: A Pilot Case-Control Study

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• Neuroblastoma (NB) is a common childhood cancer.
• Inherited factors influencing NB susceptibility are not fully understood.
• Defective microRNA (miRNA) biogenesis is linked to aggressive NB, suggesting germline variants in miRNA-processing genes as potential modifiers.

Purpose of the Study:

• To investigate the association between selected single nucleotide polymorphisms (SNPs) in key miRNA-processing genes (DICER1, DROSHA, AGO1) and neuroblastoma susceptibility.
• To assess these associations in a Greek pediatric population.

Main Methods:

• Pilot case-control study involving 200 children (25 NB cases, 175 controls) from Crete, Greece.
• Genotyping of five SNPs in DICER1, DROSHA, and AGO1 using TaqMan assays.
• Logistic regression analyses adjusted for age and sex, with Bonferroni and false discovery rate (FDR) corrections for multiple testing.

Main Results:

• The DROSHA rs3805500 SNP showed the strongest association with NB susceptibility (per G allele OR 3.43), remaining significant after multiple testing corrections.
• DROSHA rs642321 had a nominal association, and DICER1 rs3742330 showed a borderline association, neither retaining significance after corrections.
• No significant associations were found for AGO1 rs636832 or DROSHA rs10035440.

Conclusions:

• Genetic variations in the miRNA-processing pathway may influence neuroblastoma susceptibility.
• This pilot study suggests DROSHA rs3805500 as a potential genetic modifier.
• Larger, ethnically diverse cohorts and functional studies are needed for clinical validation.